Workshop on Expanding Access to Generic Medicine – Meeting Report

On 6 April 2022, the Access to Medicine Foundation convened a virtual workshop to identify solutions for strengthening the global supply of essential medicine and vaccines. The summary of the discussion has been captured in a meeting report, which is now available for download.

Participants from eight multinational generic medicine manufacturers joined the virtual workshop; other participants included experts from global health organisations, procurement agencies, and government bodies.

The workshop was held under the Chatham House Rule, in order to encourage a free and open exchange of ideas. It was chaired by the Foundation’s Chief Executive Officer Jayasree K. Iyer, and to get the discussion underway, three representatives from the generics industry were invited to speak:

Amalia Adler-Waxman, Vice President Global Head, Environment, Social & Governance, Teva Pharmaceuticals
Vinay Singh, Vice President Business Development Emerging Markets, Sun Pharma
Erika Satterwhite, Head of Global Policy, Viatris

Overarching themes:

Defining the changing roles of generic medicine manufacturers in scaling up access
Identifying viable business models to expand access
Toolkit of approaches for expanding access in LMICs

Key takeaways:

Generic medicine manufacturers have more opportunities in ensuring access to medicine, beyond their conventional role
Viable business models that build in access to medicine can, and should, be developed
Generic medicine manufacturers can build on their strengths to overcome challenges specific to LMICs

Expanding access to high-quality generic medicines

On Wednesday 6 April 2022, the Access to Medicine Foundation will host an interactive workshop, bringing together experts working with and within leading generic medicine manufacturers. Panellists and participants will discuss current and future roles of manufacturers in expanding access to essential medicines in low- and middle-income countries, drawing on practical examples and key lessons from the industry.

Our work to improve access to generic medicines

Generic medicines account for an estimated 80% of the world's supply of pharmaceuticals. Yet they are out of reach for many people in low- and middle-income countries. The Access to Medicine Foundation is bringing manufacturers to the table to increase access to generic medicines.

Workshop on Expanding Access to Generic Medicine – Meeting Report

Explore further

Expanding access to high-quality generic medicines

Taking access to the next level: mobilising five essential healthcare sectors

Our work to improve access to generic medicines

Get in touch

Claudia Martínez